The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 4, 2014, Pages 418-423

  Theede, Klaus ^a   Kiszka Kanowitz, Marianne ^a   Mertz Nielsen, Anette ^a   Nordgaard Lassen, Inge ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Disease monitoring; Fecal calprotectin; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ALBUMIN; AMINOSALICYLIC ACID; AZATHIOPRINE; C REACTIVE PROTEIN; CALGRANULIN; HEMOGLOBIN; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FECES; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; RETROSPECTIVE STUDY; SIMPLE CLINICAL COLITIS ACTIVITY INDEX; STEROID THERAPY; TREATMENT OUTCOME; ULCERATIVE COLITIS; YOUNG ADULT;

ADULT; AGED; ALBUMINS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COLITIS, ULCERATIVE; DENMARK; FECES; FEMALE; GLUCOCORTICOIDS; HEMOGLOBINS; HUMANS; LEUKOCYTE COUNT; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PREDNISOLONE; PROSPECTIVE STUDIES;

EID: 84896967000     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.883427     Document Type: Article

References (16)

1. Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, et al. Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis 2008;40:821-6.
2. Ho GT, Lee HM, Brydon G, Ting T, Hare N, Drummond H, et al. Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis. Am J Gastroenterol 2009;104:673-8.
3. Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, et al. Predicting outcome in severe ulcerative colitis. Gut 1996;38:905-10.
4. Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:524-34.
5. Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F. Accuracy of four fecal assays in the diagnosis of colitis. Dis Colon Rectum 2007;50:1697-706.
6. Roøseth AG, Aadland E, Grzyb K. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol 2004;39: 1017-20.
7. D'Incà R, Dal Pont E, Di Leo V, Ferronato A, Fries W, Vettorato MG, et al. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. Int J Colorectal Dis 2007;22:429-37.
8. Schoepfer AM, Beglinger C, Straumann A, Trummler M, Renzulli P, Seibold F. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis 2009;15:1851-8.
9. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998;43:29-32.
10. Ricanek P, Brackmann S, Perminow G, Lyckander LG, Sponheim J, Holme O, et al. Evaluation of disease activity in IBDat the time of diagnosis by the use of clinical, biochemical, and fecal markers. Scand J Gastroenterol 2011;46:1081-91.
11. Kolho K-L, Raivio T, Lindahl H, Savilahti E. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Scand J Gastroenterol 2006;41:720-5.
12. Molander P, Af Björkesten C-G, Mustonen H, Haapamäki J, Vauhkonen M, Kolho K-L, et al. Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFa blocking agents. Inflamm Bowel Dis 2012;18:2011-17.
13. De Vos M, Dewit O, D'Haens G, Baert F, Fontaine F, Vermeire S, et al. Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis. J Crohns Colitis 2012;6:557-62.
14. D'Incà R, Dal Pont E, Di Leo V, Benazzato L, Martinato M, LambogliaF, et al.Cancalprotectin predict relapse risk ininflammatory bowel disease? Am J Gastroenterol 2008;103:2007-14.
15. Gisbert JP, Bermejo F, Pérez-Calle J-L, Taxonera C, Vera I, McNicholl AG, et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 2009;15:1190-8.
16. Rogler G, Aldeguer X, Kruis W, Lasson A, Mittmann U, Nally K, et al. Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinion. J Crohns Colitis 2013;7:670-7.